Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Psoriasis (Auckland, N.Z.)|February 2, 2018
Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectivesAnna Campanati, Veronica Consales, Monia Orciani, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Drug-induced psoriasis: clinical perspectivesDeepak Mw Balak, Enes Hajdarbegovic
Psoriasis (Auckland, N.Z.)|March 23, 2026
Prevalence of Genital Psoriasis and Its Impact on Patients' Sexual Life in Routine Care: Epidemiologic Survey in GermanyToni Maria Janke, Christina Sorbe, Rachel Sommer, et al.
Psoriasis (Auckland, N.Z.)|June 3, 2026
Inflammaging and Senescence-Associated Secretory Phenotype (SASP) in Psoriasis - A Narrative Review of Potential Mechanisms and Anti-Inflammaging StrategiesKinga Filipek, Julia Nowowiejska-Purpurowicz, Iwona Flisiak
Psoriasis (Auckland, N.Z.)|April 6, 2026
Application of Trichoscopy and Novel Non-Invasive Imaging Techniques in the Diagnosis and Management of Patients with Scalp PsoriasisAleksandra Kuchnicka, Urszula Fałkowska, Piotr Konopelski, et al.
Psoriasis (Auckland, N.Z.)|February 19, 2026
Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in JapanYouran Xu, Tong Li, Chia-Ling Chang, et al.
Psoriasis (Auckland, N.Z.)|March 9, 2023
Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian PopulationValentina Perrone, Serena Losi, Silvia Sabatino, et al.
Psoriasis (Auckland, N.Z.)|April 20, 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for PsoriasisLuca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Psoriasis (Auckland, N.Z.)|August 18, 2025
TYK2 rs34536443 (P1104A) Variant Suppresses ICAM1-Mediated Inflammation: Insights From Mendelian Randomization and Functional AnalysesBowen Dai, Ye Tang, Bin Zhang, et al.
Psoriasis (Auckland, N.Z.)|August 11, 2025
Bimekizumab: The First FDA-Approved Dual IL-17A/IL-17F Inhibitor for Plaque Psoriasis - A Comprehensive Literature ReviewSukainah Ahmed Al Alshaikh, Zahra Mohammad Almarhoon, Hisham Momattin, et al.
Pageof 21